Canadian Heart Research Centre

The Canadian Heart Research Centre is a federally incorporated not-for-profit, full service academic physician organization with a sustained mission to be a national leader in the design, conduct and management of clinical trials, quality enhancement research initiatives and innovative physician educational programs devised to narrow the care and treatment gaps, improve physicians’ adherence to clinical practice guideline recommendations in the treatment and prevention of cardiovascular and metabolic diseases and their risk factors in Canada and the U.S.

Business Units:

Together with the partner logistics company, MD Primer Inc (www.mdprimer.com) there is a team of 50 experienced and dedicated employees
business units

View details »


Why the CHRC?

Reach:
  • 1,000s of Investigators collaborating in CHRC lead clinical trials, registries and/or practice enhancement programs
  • 100s of HCPs participating annually in CHRC educational programs
  • 1,000s of physicians and patients in proprietary databases

Credibility:
  • Committed to evidence based medicine & peer to peer knowledge translation in collaboration with key institutions in Canada and the US
  • Conducted over 30 major clinical trials and registries
  • Published over 200 scientific publications, including clinical practice guidelines

Confidence, Trust & Accountability
  • Experienced leadership team of cardiologists, endocrinologists, primary care and industry leaders with proven track record of success
  • Fully aware and compliant with Canadian and U.S. regulations/SOPs
 Recent CHRC Publications

  • 1, Langer, et al. Is treatment inertia unique to publicly funded healthcare? Insights from the Guidelines Oriented Approach to Lipid Lowering (GOAL) Canada Program. J Clinical Cardiology and Cardiovascular Interventions 4(7); Doi:10.31579/2641-0419/154.
  • 2, Langer A, et al. Does management of lipid lowering differ between specialists and primary care: Insights from GOAL Canada. Int J Clin Pract 2020;00:e13861.
  • 3, Langer, et al.Detection of atrial fibrillation in asymptomatic at-risk individuals. Int J Cardiol 2021 (in press).
  •  4, Lee, et al. Association Between Patient and Physician Sex and Physician-Estimated Stroke and Bleeding Risks in AtrialAssociation between patient and physician sex and physician-estimated stroke and bleeding risks in atrial fibrillation. Can J Cardiol 2019;35:160-168.
  • 5, Leiter, et al. Glycated hemoglobin level goal achievement in adults with type 2 diabetes in Canada: Still room for improvement. Can J Diabetes 2019;43(6):384-391.